Stocksigma LogoStocksigma Logo

Colinz Laboratories Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh)

■ Revenue: 155 (+11.7% YoY | +24.9% QoQ) ■ EBITDA: 8.2 (+3.1% YoY | +30.8% QoQ) ■ EBITDA Margin (%): 5.3 (-44 bps YoY | +24 bps QoQ) ■ PAT: 12.7 (-10.0%

Colinz Laboratories Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh)

Colinz Laboratories Ltd · Outcome · 29 Oct 2026, 11:03 pm

Colinz Laboratories Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh) ■ Revenue: 155 (+11.7% YoY | +24.9% QoQ) ■ EBITDA: 8.2 (+3.1% YoY | +30.8% QoQ) ■ EBITDA Margin (%): 5.3 (-44 bps YoY | +24 bps QoQ) ■ PAT: 12.7 (-10.0% YoY | -94.7% QoQ) ■ EPS (INR): 0.50 (-10.7% YoY | -94.8% QoQ)

Original exchange filing (PDF)

More announcements from Colinz Laboratories Ltd

All Colinz Laboratories Ltd announcements